Werewolf Therapeutics (HOWL) Stock: Modest 0.96% Gain Highlights Liquidity & Valuation Risks
Werewolf Therapeutics (HOWL) shows a modest 0.96 % rise amid thin liquidity and high volatility, with a 200‑day SMA far below price—investors face speculative risk.
- WEREWOLF THERAPEUTICS INC
- United States
- Health Care
- Pharmaceuticals, Biotechnology & Life Sciences
- AI generated
3 minutes to read